Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats.

Literature DB >> 20193713

Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats.

Adrie W Bruijnzeel¹, Elysia Small, Tim M Pasek, Hidetaka Yamada.

Abstract

This study investigated the role of CRF in the dysphoria-like state associated with alcohol withdrawal in rats. The intracranial self-stimulation procedure was used to assess brain reward thresholds. Cessation of chronic alcohol administration led to an elevation in brain reward thresholds in the alcohol dependent rats. The CRF receptor antagonist D-Phe CRF((12-41)) dose-dependently prevented the elevations in brain reward thresholds associated with alcohol withdrawal. This indicates that the dysphoria associated with alcohol withdrawal is at least partly mediated by the activation of central CRF receptors. Published by Elsevier B.V.

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20193713 PMCID： PMC3319063 DOI： 10.1016/j.bbr.2010.02.043

Source DB: PubMed Journal: Behav Brain Res ISSN： 0166-4328 Impact factor: 3.332

25 in total

Review 1. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence.

Authors: Adrie W Bruijnzeel; Mark S Gold
Journal: Brain Res Brain Res Rev Date: 2005-02-25

Review 2. The alcohol withdrawal syndrome.

Authors: W Hall; D Zador
Journal: Lancet Date: 1997-06-28 Impact factor: 79.321

3. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders.

Authors: Guy Griebel; Jacques Simiand; Régis Steinberg; Mireille Jung; Danielle Gully; Pierre Roger; Michel Geslin; Bernard Scatton; Jean-Pierre Maffrand; Philippe Soubrié
Journal: J Pharmacol Exp Ther Date: 2002-04 Impact factor: 4.030

4. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal.

Authors: S.C. Heinrichs; F. Menzaghi; G. Schulteis; G.F. Koob; L. Stinus
Journal: Behav Pharmacol Date: 1995-01 Impact factor: 2.293

5. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

Authors: E Merlo Pich; M Lorang; M Yeganeh; F Rodriguez de Fonseca; J Raber; G F Koob; F Weiss
Journal: J Neurosci Date: 1995-08 Impact factor: 6.167

6. Deficit in brain reward function and acute and protracted anxiety-like behavior after discontinuation of a chronic alcohol liquid diet in rats.

Authors: Daria Rylkova; Hina P Shah; Elysia Small; Adrie W Bruijnzeel
Journal: Psychopharmacology (Berl) Date: 2008-12-02 Impact factor: 4.530

7. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

Authors: S Rassnick; S C Heinrichs; K T Britton; G F Koob
Journal: Brain Res Date: 1993-03-05 Impact factor: 3.252

Review 8. A role for brain stress systems in addiction.

Authors: George F Koob
Journal: Neuron Date: 2008-07-10 Impact factor: 17.173

Review 9. A 'crash' course on psychostimulant withdrawal as a model of depression.

Authors: Alasdair M Barr; Athina Markou; Anthony G Phillips
Journal: Trends Pharmacol Sci Date: 2002-10 Impact factor: 14.819

10. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats.

Authors: Catherine A Marcinkiewcz; Melissa M Prado; Shani K Isaac; Alex Marshall; Daria Rylkova; Adrie W Bruijnzeel
Journal: Neuropsychopharmacology Date: 2009-01-14 Impact factor: 7.853

17 in total

Review 1. Corticotropin releasing factor: a key role in the neurobiology of addiction.

Authors: Eric P Zorrilla; Marian L Logrip; George F Koob
Journal: Front Neuroendocrinol Date: 2014-01-20 Impact factor: 8.606

2. Adolescent intermittent ethanol exposure diminishes anhedonia during ethanol withdrawal in adulthood.

Authors: Nathalie Boutros; Svetlana Semenova; Athina Markou
Journal: Eur Neuropsychopharmacol Date: 2014-02-04 Impact factor: 4.600

Review 3. Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors: T J Phillips; C Reed; R Pastor
Journal: Genes Brain Behav Date: 2015-01 Impact factor: 3.449

Review 4. Sex-dependent mental illnesses and mitochondria.

Authors: Akiko Shimamoto; Virginie Rappeneau
Journal: Schizophr Res Date: 2017-03-06 Impact factor: 4.939

Review 5. 21st century neurobehavioral theories of decision making in addiction: Review and evaluation.

Authors: Warren K Bickel; Alexandra M Mellis; Sarah E Snider; Liqa N Athamneh; Jeffrey S Stein; Derek A Pope
Journal: Pharmacol Biochem Behav Date: 2017-09-21 Impact factor: 3.533

Review 6. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.

Authors: Marian L Logrip; George F Koob; Eric P Zorrilla
Journal: CNS Drugs Date: 2011-04 Impact factor: 5.749

Review 7. Addiction as a stress surfeit disorder.

Authors: George F Koob; Cara L Buck; Ami Cohen; Scott Edwards; Paula E Park; Joel E Schlosburg; Brooke Schmeichel; Leandro F Vendruscolo; Carrie L Wade; Timothy W Whitfield; Olivier George
Journal: Neuropharmacology Date: 2013-06-06 Impact factor: 5.250